We are live on ! Find out more
AT

Arlington Trust Portfolio holdings

AUM $1.18B
1-Year Est. Return 11.55%
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
+11.55%
3 Year Est. Return
+55.11%
5 Year Est. Return
10 Year Est. Return
AUM
$389M
AUM Growth
+$32.4M
Cap. Flow
+$3.99M
Cap. Flow %
1.03%
Top 10 Hldgs %
58.73%
Holding
927
New
17
Increased
16
Reduced
245
Closed
433

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$623K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$554K
3
AAPL icon
Apple
AAPL
+$459K
4
MSFT icon
Microsoft
MSFT
+$395K
5
NVDA icon
NVIDIA
NVDA
+$317K

Sector Composition

Rank Sector Weight
1 Technology 11.61%
2 Financials 6.87%
3 Consumer Discretionary 3.56%
4 Healthcare 3.38%
5 Industrials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLR icon
301
Digital Realty Trust
DLR
$72.4B
$37.6K 0.01%
261
SPG icon
302
Simon Property Group
SPG
$75.1B
$36.5K 0.01%
233
-26
-10% -$3.81K
CBT icon
303
Cabot Corp
CBT
$4.61B
$35.6K 0.01%
386
-18
-4% -$1.46K
PRU icon
304
Prudential Financial
PRU
$42.3B
$34.4K 0.01%
293
-14
-5% -$1.51K
AFL icon
305
Aflac
AFL
$64.4B
$34.3K 0.01%
400
-29
-7% -$2.38K
KREF
306
KKR Real Estate Finance Trust
KREF
$471M
$34.2K 0.01%
+3,400
New +$37.3K
CVS icon
307
CVS Health
CVS
$137B
$31.9K 0.01%
400
-452
-53% -$34.5K
MRNA icon
308
Moderna
MRNA
$22.1B
$30.9K 0.01%
290
-6
-2% -$605
IFF icon
309
International Flavors & Fragrances
IFF
$19.5B
$30.5K 0.01%
355
VTRS icon
310
Viatris
VTRS
$20.5B
$29.9K 0.01%
2,500
-2,500
-50% -$30.1K
AZN icon
311
AstraZeneca
AZN
$263B
$28.6K 0.01%
211
-61
-22% -$8.08K
AZO icon
312
AutoZone
AZO
$50.2B
$28.4K 0.01%
9
USMV icon
313
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
$28.3K 0.01%
339
-1
-0.3% -$81
GILD icon
314
Gilead Sciences
GILD
$162B
$28.3K 0.01%
386
-173
-31% -$13.3K
WFC icon
315
Wells Fargo
WFC
$264B
$28.1K 0.01%
485
-32
-6% -$1.67K
GM icon
316
General Motors
GM
$78.7B
$28.1K 0.01%
619
-34
-5% -$1.32K
PXF icon
317
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.84B
$28.1K 0.01%
565
LFT
318
Lument Finance Trust
LFT
$41.2M
$27.4K 0.01%
11,000
VO icon
319
Vanguard Mid-Cap ETF
VO
$107B
$26.2K 0.01%
420
-180
-30% -$10.6K
VRTX icon
320
Vertex Pharmaceuticals
VRTX
$122B
$24.7K 0.01%
59
-8
-12% -$3.38K
MTUM icon
321
iShares MSCI USA Momentum Factor ETF
MTUM
$25.2B
$24.5K 0.01%
131
PWR icon
322
Quanta Services
PWR
$93.1B
$24.4K 0.01%
94
NVR icon
323
NVR
NVR
$16.9B
$24.3K 0.01%
3
ALB icon
324
Albemarle
ALB
$13.7B
$24.2K 0.01%
184
-22
-11% -$2.71K
SMLF icon
325
iShares US Small Cap Equity Factor ETF
SMLF
$4.1B
$24K 0.01%
378

Similar funds

Arlington Trust's Q1 2024 Portfolio in Review

As of Q1 2024, Arlington Trust held 927 positions worth $389M, up 9.1% from $357M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Arlington Trust's Q1 2024 filing shows 17 new, 16 increased, 245 reduced and 433 closed positions. Its largest new stake was Ares Commercial Real Estate: 7,000 shares worth $52.1K. The largest sale was Invesco QQQ Trust, an estimated $623K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Arlington Trust's largest Q1 2024 buy was Ares Commercial Real Estate: 7,000 shares worth $52.1K.
  • Arlington Trust added most to Vanguard Total Stock Market ETF in Q1 2024, an estimated $8.25M increase.
  • Arlington Trust's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $623K.
  • Arlington Trust fully exited Vanguard Short-Term Bond ETF in Q1 2024, selling an estimated $68.6K.
  • Arlington Trust's ten largest holdings make up 59% of its $389M portfolio in Q1 2024.
  • Arlington Trust opened 17 new positions and closed 433 in Q1 2024.
  • Arlington Trust's portfolio value rose 9.1% quarter-over-quarter to $389M.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.